CD8A and neoplasm: Analysis of the tumoral immune cell milieu revealed decreased frequencies of tumor-infiltrating CD8+ T cells on day 15 after i.t. artLCMV-TRP2 treatment in Cxcl13-Cre Il33fl/fl compared with Ctrl mice, whereas the abundance of other immune cell subsets was not substantially affected (Fig. 6d and Supplementary Fig. 7b, d).